Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Journal of Public Health and PharmacyOpen Access

Efficacy and Safety of Cannabidiol for Anxiety: A Bibliometric Analysis and Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

PFPutu Ayu Putri FajaryaniIWI Made Agus Gelgel WirasutaPSPande Made Nova Armita Sari

Discussion

Loading...

Member takes

Overview

Systematic review evaluates cannabidiol's efficacy and safety in anxiety, suggesting its potential benefits.

Key Points

  • Cannabidiol showed significant potential as an anxiolytic agent in treating anxiety disorders, indicating its efficacy.
  • A dosage of 300 mg/day in humans was effective, while animal models showed a range of 5 – 10 mg/kg for anxiolytic effects.
  • The review included a total of 64 articles, providing a comprehensive overview of cannabidiol's effects and safety.
  • Although cannabidiol appears safer than diazepam in the short term, further studies are necessary to assess its long-term safety.

Cite This Study

Fajaryani et al. (2025) studied this question.

synapsesocial.com/papers/68e034fdf0e39f13e7fa33e5https://doi.org/10.56338/jphp.v5i3.6807
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cannabidiol in the treatment of anxiety disorders: a narrative review2025
  2. 2Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study2025
  3. 3Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis2025 · 2 citations
  4. 4The effects of oral cannabidiol supplementation on blood pressure in adults: a systematic review of randomised controlled trials2026
  5. 5Endocannabinoid signaling as a potential biomarker in anxiety spectrum disorders – A case series2025